Convergence in oncology summit

September 24-25 2020 Biopôle Lausanne, Switzerland

About

The Convergence in Oncology Summit is an international annual assembly of industry leaders, entrepreneurs, and investors active in the field of Oncology to debate and explore synergies that can accelerate the development of the most promising solutions in the field.

From diagnostics to therapeutics, rapid change in technology innovation modifies the landscape faster than any organizations can keep up with. Convergence of technologies from mature and emerging sectors are creating new opportunities that can significantly accelerate disruptive solutions that benefit patients globally.

The principal aim of this Summit is to promote development of new solutions through convergence and sharing of opportunities in the field of Oncology. The Summit is organized by professionals for professionals and we look forward to welcoming you to Lausanne, Switzerland, for networking and sharing of knowledge among industry leaders, entrepreneurs, academics and investors.

Session Highlights

This year’s Summit will focus on Prevention & Diagnostics, Therapy, and Digitization, with many opportunities to network and explore synergies.

The Summit is organized in several consecutive sessions led by a panel of industry leaders bringing their perspective to the topic, followed by several presentations by leading company CEOs covering innovative emerging and disrupting solutions relevant to the panel discussion.

Who should attend?

The annual event is attended by CEOs, entrepreneurs, investors, and thought leaders from both academia and industry to discuss and debate the key issues of global concern in Oncology.

Schedule 2019

The Summit is organized around seven consecutive plenary panel sessions over two days.

18:00
VIP & Speakers Dinner (invitation-only)
11:00>12:45
Registration and Welcome Lunch
12:45>13:15
Official Opening
Brian Hashemi, Salus Partners
Nasri Nahas, Biopôle SA
Raphael Conz, State of Vaud
13:15 > 14:30
Advances in Molecular Diagnostics
Early Cancer Detection & Therapy Optimization
Panel chair: Jan Groen, Novigenix

Ralf Hoffmann, Philips Research
Manon Van Engeland, University of Maastricht
Gitte Pedersen, Genomic Expression
Venturi Miro, Roche Diagnostics
Max van Min, Cergentis
14:30>15:45
Artificial Intelligence in Oncology
Mastering Signal to Noise
Panel chair: Stephan Morgenthaler, EPFL

Christophe Patris de Broe Zeilas, DeepCube
Win Van Criekinge, Ghent University
Andrea Dunbar, CSEM
Jack Kuipers, ETH Zurich
16:30>17:45
Convergence for Better Health Outcomes
Panel chair: William Burns, Molecular Partners

Pedro Romero, CHUV
Miro Venturi, Roche Diagnostics
Ebrahim S. Delpassand, Radiomedix
Ayse Baker, Chugai Pharma
Herb Riband, Stanford University
18:00>18:30
Salus Excellence Award
19:00>21:30
Aquatis Journey Dinner
21:30>23:00
Evening Networking
08:00>09:00
Wake up coffee
09:00>10:15
Health & Economics
Prevention and Holistic Solutions to Benefit Patients and Society
Panel chair: Herb Riband, Stanford University

Rebecca Morton Doherty, C/Can City Cancer Challenge
Suzanne Wait, The Health Policy Partnership
Herve Lamarque, Incyte
Manuela Eicher, CHUV
Xavier Franz, Varian
10:45>12:00
Medical Devices in Oncology
A New Generation of Therapeutic Companions
Panel chair: Diana Saraceni, Panakes

Antonino Amato, BetaGlue
Eugene Bajorinas, Novian Health
Thomas Hefti, Novocure
Ata Tuna Ciftlik, Lunaphore
Bastien Rachet, SamanTree Medical
12:00 > 13:30
Networking Lunch
13:30>14:45
Emerging Nuclear Medicines
A New Era for Targeted Therapy
Panel chair: Ebrahim S. Delpassand, RadioMedix

Andreas Kjaer, University of Copenhagen
Julien Dodet, Orano Med
Thomas Travis, Advanced Accelerator Applications (AAA)
Alexander McEwan, Ipsen

15:15>16:30
Regulatory Affairs
Accelerating Regulatory Approval of Novel Solutions
Panel chair: Ayse Baker, Chugai Pharma

Stella Augustus, Seattle Genetics
Laura Millichamp, InsideReg
Vann Parker, Precision For Medicine
16:30>17:30
Farewell Apero
17:30
End of The Convergence in Oncology Summit 2019

 Industry Leaders     Entrepreneurs     Investors
• Panel discussions • Company presentations  • Investment outlook
Digitization    Prevention    Diagnostics    Therapeutics

Confirmed Speakers 2019

Antonino
Amato
Stella
Augustus
Eugene
Bajorinas
Ayse
Baker
William
Burns
Ata Tuna
Ciftlik
Raphael
Conz
Ebrahim
Delpassand
Julien
Dodet
Andrea
Dunbar
Manuela
Eicher
Xavier
Franz
Jan
Groen
Brian
Hashemi
Thomas
Hefti
Ralf
Hoffmann
Andreas
Kjaer
Jack
Kuipers
Herve
Lamarque
Alexander
McEwan
Laura
Millichamp
Stephan
Morgenthaler
Rebecca
Morton Doherty
Nasri
Nahas
Vann
Parker
Christophe
Patris de Broe Zeilas
Gitte
Pedersen
Bastien
Rachet
Herb
Riband
Pedro
Romero
Diana
Saraceni
Frederic
Sottilini
Thomas
Travis
Wim
Van Criekinge
Manon
Van Engeland
Max
van Min
Miro
Venturi
Suzanne
Wait

Speakers 2018

Patrick
Amstutz
Christina
Busmalis
Jurgi
Camblong
Raphael
Conz
Erik 
de Heus
Antoine
De Weck
Nicolas
Demierre
Sorin
Draghici
Tania
Dussey-Cavassini
Brian
Hashemi
Lana
Kandalaft
Catherine
Labouchère
Nicolas
Mach
Chris
Martin
Olivier
Michielin
Nasri
Nahas
Vincent
Ossipow
Vaclav
Potesil
Venkat
Reddy
Heinrich
Röder
Christopher
Rudolf
Diana
Saraceni
Marc
Sluijs
Cristina
Stefan
Kurt
Stoeckli
Hiroaki
Tanaka
Thierry
Weber
Karen
Zinkewich-Peotti

ATTENDING ORGANIZATIONS

Location

Aquatis Conference Center @Biopôle Lausanne
Route de Berne 148
1010 Lausanne
Switzerland

Venue

Aquatis is located at Biopôle Lausanne, one-hour journey from Geneva Airport and 15 minutes from Lausanne train station. It hosts a Conference Center, a Hotel, and the largest freshwater aquarium-vivarium in Europe. The superior business hotel houses a magnificent modern conference centre, restaurants, and a terrace, located in Lausanne-Vennes, just off the A9 motorway. The hotel has straight access to the M2 metro station at Vennes, with direct connections to Lausanne city centre and the lakeside area of Lac Leman.

Accommodation

For attendees of the Convergence in Oncology Summit 2019, the following hotels offer special room rates.

A limited number of hotel rooms are available at the Conference Hotel Aquatis. Program attendees, speakers and guests may benefit for the special rate of CHF 160.00 CHF single or double occupancy, breakfast included.

 

 

 

Book Now

Hotel rooms are available at Alpha-Palmiers by Fassbind ****.
Book directly on the website to have a discounted price.
The hotel is located 2 minutes walk from M2 metro station that directly brings to the Aquatis Conference Center.

 

 

 

Book Now

Hotel rooms are available at Agora Swiss Night by Fassbind ****.
Book directly on the website to have a discounted price.
The hotel is located 1 minute walk from M2 metro station that directly brings to the Aquatis Conference Center.

 

 

 

Book Now

Hotel rooms are available at Swiss Wine by Fassbind ***.
Book directly on the website to have a discounted price.
The hotel is located 1 minute walk from M2 metro station that directly brings to the Aquatis Conference Center.

 

 

 

Book Now

Hotel rooms are available at Hotel Lausanne by Fassbind **.
Book directly on the website to have a discounted price.
The hotel is located 2 minute walk from M2 metro station that directly brings to the Aquatis Conference Center.

 

 

 

Book Now

«When talking about Oncology, time is of essence and shortening. The only option we have left today is to converge and work together to speed up oncology research.» Nasri Nahas, CEO Biopôle

Organizers & Sponsors

Biopôle Lausanne is home of Life Sciences innovations in Switzerland. Biopôle hosts a vibrant community where industry and academia share a world-class combination of infrastructure, added value services, living space. Today, it houses more than 75 companies and clinical development teams, a startup incubator and 25 world-famous research groups. Biopôle SA is the owner of the site on which the Biopôle Lausanne life science campus is situated. Biopôle SA makes sure to insure the proper development of the site, to promote the site as a major place to be in the life sciences in Europe and to manage a lively community.

Salus Partners SA is a Swiss asset management firm based in Lausanne, Switzerland. The company has a special expertise in proven health technologies and seeks to generate exceptional returns while bringing good outcomes to society.

Keep me posted

Subscribe our contact list to receive updates about the Convergence in Oncology Summit 2019.